<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45985">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02507596</url>
  </required_header>
  <id_info>
    <org_study_id>Nanobone_IBD</org_study_id>
    <nct_id>NCT02507596</nct_id>
  </id_info>
  <brief_title>Evaluation of Nano-crystalline Hydroxyapatite Silica Gel in Management of Periodontal Intrabony Defects</brief_title>
  <official_title>Clinical and Radiographic Evaluation of Nano-crystalline Hydroxyapatite Silica Gel in the Treatment of Human Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical and radiographic evaluation of Nano-crystalline hydroxyapatite silica gel in
      comparison with bone allograft and open flap debridement for management of periodontal
      intrabony defects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty patients suffering from advanced chronic periodontitis were included in this
      randomized controlled clinical trial. Each subject contributed matched two- or three-walled
      intrabony defects. Patients were equally randomly assigned into the experimental group;
      Nano-crystalline hydroxyapatite silica gel or the positive control group; bone allograft or
      negative control group;open flap debridement. Clinical and radiographic parameters were
      recorded at baseline and at 3 and 6 months postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical attachment level</measure>
    <time_frame>change from Baseline at 6 months</time_frame>
    <description>Change from baseline in clinical attachment level in mm in chronic periodontitis patients at 6 month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pocket depth</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Estimation of pocket depth in mm in chronic periodontitis patients at baseline and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone defect area</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Estimation of bone fill defect area in mm square in chronic periodontitis patients at baseline and 6 month</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Nano-crystalline hydroxyapatite silica gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hydroxyapaptite bone graft with nano particle size in silica gel will be used to fill in the defect after opening a periodontal flap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone allograft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>commercially available demineralized freeze-dried bone allograft will be used to fill in the defect after opening a periodontal flap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open flap debridement</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>an open periodontal flap without adding bone graft.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Nano-crystalline hydroxyapatite silica gel</intervention_name>
    <description>it is a type of synthetic bone graft.</description>
    <arm_group_label>Nano-crystalline hydroxyapatite silica gel</arm_group_label>
    <other_name>Nanobone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bone allograft</intervention_name>
    <description>it is a type of bone graft from human cadavers.</description>
    <arm_group_label>Bone allograft</arm_group_label>
    <other_name>DFDBA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open flap debridement</intervention_name>
    <description>a periodontal surgical procedure for the purpose of debridement.</description>
    <arm_group_label>Open flap debridement</arm_group_label>
    <other_name>OFD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe chronic periodontitis patients.

          -  having at least one site with pocket depth ≥ 6 mm and clinical attachment level ≥ 5
             mm, with radiographic evidence of bone loss as detected in periapical radiographs.

        Exclusion Criteria:

          -  Pregnant women

          -  Subjects had &lt;22 permanent teeth

          -  Having any given systemic disease

          -  Taking any type of medication and/or antibiotic therapy during the 3 months before
             the study

          -  Received periodontal treatment within the past 12 months Current or former smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weam Battawy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Lecturer of Oral Medicine and Periodontology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Noha Ghallab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor of Oral Medicine and Periodontology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dalia AbdelHamid, MD</last_name>
    <role>Study Director</role>
    <affiliation>Associate Professor of Biomaterials</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riham Hamdy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Associate Professor of Oral and Maxillofacial Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noha Ghallab, MD</last_name>
    <phone>+201005263365</phone>
    <email>noha.ghallab@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Oral and Dental Medicine, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noha Ghallab, MD</last_name>
      <phone>+201005263365</phone>
      <email>noha.ghallab@dentistry.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol. 2003 Dec;8(1):227-65. Review.</citation>
    <PMID>14971256</PMID>
  </reference>
  <reference>
    <citation>Heinz B, Kasaj A, Teich M, Jepsen S. Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study. Clin Oral Investig. 2010 Oct;14(5):525-31. doi: 10.1007/s00784-009-0325-x. Epub 2009 Aug 13.</citation>
    <PMID>19680697</PMID>
  </reference>
  <reference>
    <citation>Kasaj A, Röhrig B, Zafiropoulos GG, Willershausen B. Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical trial: 6-month results. J Periodontol. 2008 Mar;79(3):394-400. doi: 10.1902/jop.2008.070378 .</citation>
    <PMID>18315420</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 28, 2016</lastchanged_date>
  <firstreceived_date>July 13, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Noha Ayman Ghallab</investigator_full_name>
    <investigator_title>Associate Professor of Oral Medicine and Periodontology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
